BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1339 related articles for article (PubMed ID: 24374115)

  • 1. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.
    Abdallah CG; Fasula M; Kelmendi B; Sanacora G; Ostroff R
    J ECT; 2012 Sep; 28(3):157-61. PubMed ID: 22847373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression.
    Zhang M; Rosenheck R; Lin X; Li Q; Zhou Y; Xiao Y; Huang X; Fan N; He H
    J Affect Disord; 2018 Feb; 227():372-378. PubMed ID: 29149755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.
    Ibrahim L; Diazgranados N; Luckenbaugh DA; Machado-Vieira R; Baumann J; Mallinger AG; Zarate CA
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1155-9. PubMed ID: 21466832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
    DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA
    J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Low Dose of Ketamine on Learning Memory Function in Patients Undergoing Electroconvulsive Therapy-A Randomized, Double-Blind, Controlled Clinical Study.
    Chen Q; Min S; Hao X; Peng L; Meng H; Luo Q; Chen J; Li X
    J ECT; 2017 Jun; 33(2):89-95. PubMed ID: 27828927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder: A Pilot Study.
    Kheirabadi D; Kheirabadi GR; Mirlohi Z; Tarrahi MJ; Norbaksh A
    J Clin Psychopharmacol; 2020; 40(6):588-593. PubMed ID: 33060432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder.
    Wang X; Chen Y; Zhou X; Liu F; Zhang T; Zhang C
    J ECT; 2012 Jun; 28(2):128-32. PubMed ID: 22622291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
    Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant effects of ketamine and ECT: A pilot comparison.
    Sharma RK; Kulkarni G; Kumar CN; Arumugham SS; Sudhir V; Mehta UM; Mitra S; Thanki MV; Thirthalli J
    J Affect Disord; 2020 Nov; 276():260-266. PubMed ID: 32697707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.
    Zarate CA; Mathews D; Ibrahim L; Chaves JF; Marquardt C; Ukoh I; Jolkovsky L; Brutsche NE; Smith MA; Luckenbaugh DA
    Biol Psychiatry; 2013 Aug; 74(4):257-64. PubMed ID: 23206319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.
    Luckenbaugh DA; Ibrahim L; Brutsche N; Franco-Chaves J; Mathews D; Marquardt CA; Cassarly C; Zarate CA
    Bipolar Disord; 2012 Dec; 14(8):880-7. PubMed ID: 22978511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.
    Machado-Vieira R; Yuan P; Brutsche N; DiazGranados N; Luckenbaugh D; Manji HK; Zarate CA
    J Clin Psychiatry; 2009 Dec; 70(12):1662-6. PubMed ID: 19744406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
    Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB;
    Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
    Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
    J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant effects of ketamine in depressed patients.
    Berman RM; Cappiello A; Anand A; Oren DA; Heninger GR; Charney DS; Krystal JH
    Biol Psychiatry; 2000 Feb; 47(4):351-4. PubMed ID: 10686270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.